Brief: Shanghai Haohai Biological's H1 Net Profit Up 739.3% Y/Y
26/08/2021 10:35
Aug 26 (Reuters) - Shanghai Haohai Biological Technology Co
Ltd 688366.SS :
* SAYS H1 NET PROFIT UP 739.3% Y/Y AT 231.0 MILLION YUAN
($35.63
million)
Source text http://static.sse.com.cn/disclosure/listedinfo/announcement/c/new/2021-08-27/688366_20210827_1_6OAlzlZC.pdf
Further company coverage: 688366.SS 6826.HK
($1 = 6.4833 Chinese yuan renminbi)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.